CVU vs GRNQ

CVU exhibits severe fundamental deterioration, highlighted by a critical Piotroski F-Score of 0/9, indicating failure across all health benchmarks. While the stock has seen a 50% price surge over the last six months, this momentum is decoupled from financial reality, as both revenue and earnings growth are deeply negative. The company maintains a healthy liquidity position (Current Ratio 1.89), but negative profit margins and a lack of growth suggest a value trap. The deterministic health scores signal high risk despite a low Price-to-Sales ratio.

GRNQ exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic profit margin of -143.83%. While the stock has experienced a speculative price surge over the last year (+224.3%), this movement is completely decoupled from fundamentals, as revenue has plummeted by 53.50% YoY. With a Price-to-Sales ratio of 23.70 and no positive earnings to support a Graham Number or Intrinsic Value, the company is currently valued as a high-risk speculative vehicle rather than a viable business. The combination of shrinking top-line growth and deep operational losses suggests a precarious long-term outlook.